Applying Shared Decision Making to the Process of Medication Deprescribing in Schizophrenia.
Deprescribing
Medication optimization
Schizophrenia
Serious mental illness
Shared decision making
Journal
Clinical therapeutics
ISSN: 1879-114X
Titre abrégé: Clin Ther
Pays: United States
ID NLM: 7706726
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
24
05
2023
revised:
11
07
2023
accepted:
24
07
2023
medline:
13
11
2023
pubmed:
12
8
2023
entrez:
11
8
2023
Statut:
ppublish
Résumé
Deprescribing, the identification and discontinuation of medications that are no longer indicated or that cause adverse effects that outweigh clinical benefit, relies on the integration of clinical expertise and patient values using shared decision making (SDM). This case series describes the application of SDM to the process of deprescribing in patients with serious mental illness, illustrating the ways in which SDM builds a therapeutic alliance between patient, psychiatrist, family members, and other health care professionals to collaboratively develop treatment plans.
Identifiants
pubmed: 37567844
pii: S0149-2918(23)00266-7
doi: 10.1016/j.clinthera.2023.07.016
pii:
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1008-1011Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest This research was not funded by any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors have indicated that they have no conflicts of interest with regard to the content of this article.